Patients benefit from personalized treatment plans that consider their overall well-being, promoting a better quality of life
nih Jastreboff A.M., Kaplan L.M., Fras J.P., Wu Q., Du Y., Gurbuz S., Coskun T., Haupt A., Milicevic Z., Hartman M.L
Approximately 70% of an oral dose is absorbed in the small intestine, minimally metabolised, and excreted unchanged in urine within 24 hours
Another observational study, which looked at data collected between 2004 and 2021, showed that while there was no overall increase in risk of tumors in patients, the data did suggest there was a trend showing increased risk of certain cancers including thyroid in GLP-1 drug users
Both findings matter, but they come from different programs, with different timelines and study designs